TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10432161

Group type: EXPERIMENTAL
Intervention: 72-hour intravenous tubing set changes
Number of subjects: 2213

Group type: COMPARATOR
Intervention: 24-hour intravenous tubing set changes
Number of subjects: 2213
Study: 2173390

Group type: EXPERIMENTAL
Intervention: Pectin-enriched cereal
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Psyllium-enriched cereal
Number of subjects: 58

Group type: COMPARATOR
Intervention: Diet-only phase
Number of subjects: 58
Study: 330480

Group type: COMPARATOR
Intervention: 375 mg amoxycillin three times daily
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: 400 mg pivmecillinam three times daily
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: 200 mg pivmecillinam three times daily
Number of subjects: 298
Study: 30948254

Group type: EXPERIMENTAL
Intervention: Elastic tourniquet (ET)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Blood pressure cuff (BPC)
Number of subjects: 121
Study: 28257752

Group type: EXPERIMENTAL
Intervention: Idelalisib plus ofatumumab (oral idelalisib 150 mg twice daily continuously plus ofatumumab 300 mg intravenously in week 1, then 1000 mg intravenously weekly for 7 weeks, and every 4 weeks for 16 weeks)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Ofatumumab alone (ofatumumab dosing as per the combination group, except 2000 mg was substituted for the 1000 mg dose)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Idelalisib plus ofatumumab
Number of subjects: 261

Group type: COMPARATOR
Intervention: Ofatumumab
Number of subjects: 261
Study: 25981401

Group type: EXPERIMENTAL
Intervention: Tadalafil (1 day prior to NSS and 2 days following surgery)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no tadalafil treatment)
Number of subjects: 49
Study: 24075657

Group type: EXPERIMENTAL
Intervention: Multimedia information (DVD) plus verbal information
Number of subjects: 90

Group type: COMPARATOR
Intervention: Verbal information alone
Number of subjects: 90
Study: 21810659

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent
Number of subjects: 300

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent
Number of subjects: 300
Study: 19253237

Group type: EXPERIMENTAL
Intervention: Tafluprost 0.0015% (once daily) with timolol 0.5% (twice daily)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Vehicle with timolol 0.5% (twice daily)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Tafluprost after switching from vehicle
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Tafluprost
Number of subjects: 185
Study: 17092274

Group type: EXPERIMENTAL
Intervention: Viewing positive images of dentistry
Number of subjects: 38

Group type: COMPARATOR
Intervention: Dentally neutral images (Control)
Number of subjects: 38
Study: 15349735

Group type: EXPERIMENTAL
Intervention: Short battery consisting of two bedside tests
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Short battery consisting of two bedside tests (with changed criteria)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 45-min neuropsychological screening battery (gold standard)
Number of subjects: 40
Study: 11323730

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9468460

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA; 10 mg/kg)
Number of subjects: 18
Study: 8560834

Group type: EXPERIMENTAL
Intervention: Indobufen 400 mg perorally, given one day prior to operation and continued daily for three months
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Indobufen treatment
Number of subjects: 15
Study: 2884190

Group type: EXPERIMENTAL
Intervention: Mifentidine (10 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29174109

Group type: EXPERIMENTAL
Intervention: 2D of AS04-HPV-16/18
Number of subjects: 1075

Group type: COMPARATOR
Intervention: 2D of 4vHPV
Number of subjects: 1075

Group type: COMPARATOR
Intervention: 3D of 4vHPV
Number of subjects: 1075
Study: 26718605

Group type: COMPARATOR
Intervention: IV delafloxacin (300 mg)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Oral delafloxacin (450 mg)
Number of subjects: 130
Study: 25754300

Group type: EXPERIMENTAL
Intervention: Behavioral economics strategies during home dinner meal occasions for 6 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study: 22340966

Group type: EXPERIMENTAL
Intervention: Group CBT (1:1 allocation); one 90 min session a week for 6 weeks.
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual care; control group.
Number of subjects: 96
Study: 21092137

Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine (Coartem®)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: artesunate plus mefloquine (Artequin™)
Number of subjects: 470
Study: 18536065

Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 0
Study: 15960642

Group type: COMPARATOR
Intervention: Ropivacaine 0.2% 0.75 ml.kg(‐1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% 0.75 ml.kg(‐1) plus clonidine 1 microg.kg(‐1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% 0.75 ml.kg(‐1) plus ketamine 0.5 mg.kg(‐1)
Number of subjects: 75
Study: 12610006

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 448

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 448
Study: 10348223

Group type: EXPERIMENTAL
Intervention: Malarone (250 mg of atovaquone/100 mg of proguanil hydrochloride per tablet)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 7491835

Group type: EXPERIMENTAL
Intervention: Transdermal 17 beta‐estradiol matrix patch (0.05 mg/day)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Oral conjugated equine estrogens (0.625 mg/day)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Transdermal 17 beta‐estradiol matrix patch
Number of subjects: 166

Group type: COMPARATOR
Intervention: Oral conjugated equine estrogens
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 166
Study: 1781046

Group type: EXPERIMENTAL
Intervention: DBCG 77a (1977‐1982)
Number of subjects: 7315

Group type: EXPERIMENTAL
Intervention: DBCG 82a (1982‐1990)
Number of subjects: 7315
Study: 161858

Group type: EXPERIMENTAL
Intervention: Oral contraceptive containing 0.05 mg of ethinylestradiol and 0.100 mg or 0.125 mg of a new progestogen (17 alpha‐ethinyl‐18‐methylene‐4‐estren‐17 beta‐ol)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control cycle
Number of subjects: 7
Study: 30989638

Group type: EXPERIMENTAL
Intervention: Disease-metaphoric description of plagiarism
Number of subjects: 365

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 365
Study: 31172416

Group type: EXPERIMENTAL
Intervention: pegylated-interferon (peg-IFN) consolidation treatment for 48 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: nucleos(t)ide analogue (NA) consolidation treatment for 48 weeks
Number of subjects: 48
Study: 28857592

Group type: EXPERIMENTAL
Intervention: High-intensity interventions
Number of subjects: 1512

Group type: COMPARATOR
Intervention: Low-intensity interventions
Number of subjects: 1512

Group type: COMPARATOR
Intervention: Standard cases (St)
Number of subjects: 1512

Group type: EXPERIMENTAL
Intervention: Complex cases (Cx)
Number of subjects: 1512
Study: 26156667

Group type: EXPERIMENTAL
Intervention: Synthesized right-sided chest ECG (Syn-ECG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: New criteria from Syn-ECG
Number of subjects: 30
Study: 23364679

Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 15
Study: 21908720

Group type: EXPERIMENTAL
Intervention: Characterized chondrocyte implantation (CCI)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Microfracture (MF)
Number of subjects: 112
Study: 19628801

Group type: EXPERIMENTAL
Intervention: Attention Process Training (APT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 78
Study: 17083722

Group type: EXPERIMENTAL
Intervention: GP-initiated preconception counselling (PCC)
Number of subjects: 1656

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 1656
Study: 15255491

Group type: EXPERIMENTAL
Intervention: Municipality intervention with education for primary care professionals and GPs' short assessment programme
Number of subjects: 4060

Group type: EXPERIMENTAL
Intervention: Accepting and receiving free preventive home visits
Number of subjects: 4060
Study: 11235127

Group type: EXPERIMENTAL
Intervention: Emergency ambulance utilization
Number of subjects: 2294

Group type: EXPERIMENTAL
Intervention: Reasons for requesting EA
Number of subjects: 2294

Group type: EXPERIMENTAL
Intervention: Improper use of EA
Number of subjects: 2294

Group type: EXPERIMENTAL
Intervention: Regulatory compliance of EA use
Number of subjects: 2294
Study: 9306146

Group type: EXPERIMENTAL
Intervention: Stress imaging with Tc‐99m MIBI SPECT
Number of subjects: 460
Study: 8379288

Group type: EXPERIMENTAL
Intervention: Bair Hugger
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reflective blanket
Number of subjects: 60

Group type: COMPARATOR
Intervention: Humidistat
Number of subjects: 60

Group type: COMPARATOR
Intervention: Heated humidifier
Number of subjects: 60
Study: 31649349

Group type: EXPERIMENTAL
Intervention: Clear lens extraction (CLE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prophylactic laser peripheral iridotomy (PI)
Number of subjects: 0
Study: 29962050

Group type: EXPERIMENTAL
Intervention: Evolocumab 140 mg every 2 weeks (Q2W)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg every month (QM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo Q2W
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo QM
Number of subjects: 100
Study: 26862823

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (8 weekly sessions)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no psychoeducational intervention)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Overall allograft survival rate
Number of subjects: 110
Study: 24827879

Group type: EXPERIMENTAL
Intervention: ED-initiated AF clinical pathway with early follow-up in a specialty AF outpatient clinic
Number of subjects: 100
Study: 22902422

Group type: EXPERIMENTAL
Intervention: Artificial silicon retina (ASR) implantation
Number of subjects: 8
Study: 20122306

Group type: EXPERIMENTAL
Intervention: Group membership primed with increasing group size
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagining others as women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group size increase
Number of subjects: 0
Study: 16403233

Group type: COMPARATOR
Intervention: Intravenous cimetidine 800 mg per day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Oral omeprazole 40 mg per day
Number of subjects: 80
Study: 15569787

Group type: EXPERIMENTAL
Intervention: Generic stibogluconate
Number of subjects: 114

Group type: COMPARATOR
Intervention: Branded pentavalent antimony (Pentostam or Glucantime)
Number of subjects: 114
Study: 11672550

Group type: EXPERIMENTAL
Intervention: 20 microg ethinyl estradiol/100 microg levonorgestrel (LNG)
Number of subjects: 704

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 704
Study: 9427888

Group type: EXPERIMENTAL
Intervention: Vitamin E prophylaxis
Number of subjects: 704

Group type: COMPARATOR
Intervention: Control
Number of subjects: 704
Study: 8499355

Group type: EXPERIMENTAL
Intervention: Fluoromethalone 0.1%
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.1%
Number of subjects: 2

Group type: COMPARATOR
Intervention: Both twins on identical tapering regimen of corticosteroids over 3 months
Number of subjects: 2
Study: 3318799

Group type: EXPERIMENTAL
Intervention: Scopolamine 0.6 mg with d-amphetamine 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scopolamine 0.6 mg with d-amphetamine 5 mg and neostigmine 15 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neostigmine 15 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motion sickness (induced by head movements in a rotating chair)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29167081

Group type: EXPERIMENTAL
Intervention: Leg crossing and muscle tensing technique during PIV placement
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard care during PIV placement
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Leg crossing and muscle tensing technique
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 28
Study: 26568469

Group type: EXPERIMENTAL
Intervention: Preventive home visit
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Multiprofessional senior group meetings
Number of subjects: 459
Study: 24884501

Group type: EXPERIMENTAL
Intervention: Nordic FLOX + cetuximab
Number of subjects: 504

Group type: COMPARATOR
Intervention: Nordic FLOX
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Nordic FLOX and Nordic FLOX + cetuximab
Number of subjects: 504
Study: 22409993

Group type: EXPERIMENTAL
Intervention: Modified laparoscopic sleeve gastrectomy (MLSG)
Number of subjects: 150
Study: 19693508

Group type: EXPERIMENTAL
Intervention: Strengthening exercise program with EMG‐biofeedback
Number of subjects: 40

Group type: COMPARATOR
Intervention: Strengthening exercise program without biofeedback
Number of subjects: 40
Study: 18329189

Group type: COMPARATOR
Intervention: Good Behavior Game (GBG)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Mastery Learning (ML)
Number of subjects: 19
Study: 15963119

Group type: EXPERIMENTAL
Intervention: LHRH agonist treatment for 3-5 months before radical radiotherapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no prostate cancer)
Number of subjects: 32
Study: 15500759

Group type: EXPERIMENTAL
Intervention: LASEK
Number of subjects: 46

Group type: COMPARATOR
Intervention: PRK
Number of subjects: 46
Study: 11393207

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate cream (Temovate®) applied twice daily for 3 or 4 weeks
Number of subjects: 0
Study: 9278462

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (tinzaparin)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 612
Study: 8495602

Group type: EXPERIMENTAL
Intervention: DuoDERM (occlusive adhesive dressing)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Steristrip plus Cutiplast (conventional absorbent wound dressing)
Number of subjects: 88
Study: 3501728

Group type: EXPERIMENTAL
Intervention: Ro 15-8081 (10 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ro 15-8081 (25 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ro 15-8081 (50 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Codeine (60 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29753374

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400mg b.i.d. plus losartan 50mg daily
Number of subjects: 59

Group type: COMPARATOR
Intervention: Losartan 50mg b.i.d.
Number of subjects: 59
Study: 27124410

Group type: EXPERIMENTAL
Intervention: Guided neoadjuvant chemotherapy (guided‐NACT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional neoadjuvant chemotherapy (conventional‐NACT)
Number of subjects: 0
Study: 26404395

Group type: EXPERIMENTAL
Intervention: Levosulpiride 50 mg tablets, 3 times daily
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Levosulpiride 50 mg injection (IM), twice daily
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Levosulpiride (PO)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Levosulpiride (IM)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Levosulpiride (PO and IM)
Number of subjects: 42
Study: 24350692

Group type: EXPERIMENTAL
Intervention: DSL v4.1
Number of subjects: 200

Group type: COMPARATOR
Intervention: NAL-NL1
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: DSL m[i/o]
Number of subjects: 200

Group type: COMPARATOR
Intervention: NAL-NL2
Number of subjects: 200
Study: 21360537

Group type: EXPERIMENTAL
Intervention: Subareolar injection of methylene blue (MB)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Peritumoral injection of methylene blue (MB)
Number of subjects: 126
Study: 18317199

Group type: EXPERIMENTAL
Intervention: etoricoxib 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: etoricoxib 90 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 17184507

Group type: EXPERIMENTAL
Intervention: [(13)C]‐acetate breath test (ABT) with 100 mg [(13)C]‐acetate and 200 kcal liquid meal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High viscosity meal (gel-forming agent added)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Scintigraphy
Number of subjects: 8
Study: 14519265

Group type: EXPERIMENTAL
Intervention: A.H.C.P.R. Practice Guidelines
Number of subjects: 31

Group type: COMPARATOR
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Evidence-based recommendations
Number of subjects: 31
Study: 10851707

Group type: EXPERIMENTAL
Intervention: Organized inpatient stroke unit care
Number of subjects: 3864
Study: 8736513

Group type: EXPERIMENTAL
Intervention: Bubble oxygenators
Number of subjects: 20

Group type: COMPARATOR
Intervention: Membrane oxygenators
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both oxygenator types
Number of subjects: 20
Study: 1484192

Group type: EXPERIMENTAL
Intervention: Controlled-release morphine (CRM) suspension (SAR 213)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Controlled-release morphine (CRM) tablets (Moscontin)
Number of subjects: 52
Study: 3975798

Group type: EXPERIMENTAL
Intervention: Prophylactic cephapirin sodium
Number of subjects: 85

Group type: COMPARATOR
Intervention: No prophylactic antibiotics
Number of subjects: 85
Study: 30656609

Group type: EXPERIMENTAL
Intervention: Self-regulation group (writing about deepest feelings, stress coping, and finding benefits)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cancer-fact group (writing about cancer experience objectively)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Emotional disclosure group (writing about deepest feelings)
Number of subjects: 96
Study: 27885425

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM) - single injection 4 µg/kg before skin incision (n = 23)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Intravenous opioids (IVO) - iv remifentanil infusion during surgery followed by i.v. bolus of morphine, 0.15 mg/kg before the end of surgery (n = 26)
Number of subjects: 49
Study: 26680399

Group type: EXPERIMENTAL
Intervention: Gamma® nail
Number of subjects: 81

Group type: COMPARATOR
Intervention: ENDOVIS® nail
Number of subjects: 81
Study: 23422395

Group type: EXPERIMENTAL
Intervention: Zotepine
Number of subjects: 59
Study: 21299684

Group type: EXPERIMENTAL
Intervention: Caudal block with 0.7 ml·kg(‐1) of 1.0% lidocaine containing epinephrine at 5 μg·ml(‐1)
Number of subjects: 52

Group type: COMPARATOR
Intervention: General anesthesia alone (control group)
Number of subjects: 52
Study: 19193493

Group type: EXPERIMENTAL
Intervention: Low levels of structure provided by parents in middle childhood
Number of subjects: 53
Study: 16401430

Group type: EXPERIMENTAL
Intervention: Upper-extremity exercise program (1h/session, 3 sessions/week for 19 weeks)
Number of subjects: 63
Study: 15133920

Group type: EXPERIMENTAL
Intervention: Brief tailored counselling intervention
Number of subjects: 287

Group type: COMPARATOR
Intervention: Health counselling not tailored to exercise behaviour
Number of subjects: 287
Study: 11758229

Group type: EXPERIMENTAL
Intervention: Warfarin therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: M group and L group (moderate and major renal dysfunction)
Number of subjects: 46
Study: 9218948

Group type: EXPERIMENTAL
Intervention: Erythromycin 500 mg orally every 8 h for 10 days
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (no antibiotics)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 35
Study: 8251278

Group type: EXPERIMENTAL
Intervention: 6 units of alcohol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3 units of alcohol
Number of subjects: 10

Group type: COMPARATOR
Intervention: No alcohol (control)
Number of subjects: 10
Study: 3307487

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.7 ml of Alcohol per kg body weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1 ml of Alcohol per kg body weight
Number of subjects: 0
Study: 31756120

Group type: EXPERIMENTAL
Intervention: Koch compressions
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional compressions
Number of subjects: 18
Study: 30855234

Group type: EXPERIMENTAL
Intervention: Superfast broadband implementation
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Practice-level discussions with general practitioners
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Household-level tailored booklets
Number of subjects: 1388

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1388
Study: 28858134

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 200
Study: 26481885

Group type: EXPERIMENTAL
Intervention: Modified Widman flap (MWF) surgery with diode laser (DL) (810 nm)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Modified Widman flap (MWF) surgery alone
Number of subjects: 25
Study: 23150720

Group type: EXPERIMENTAL
Intervention: Triple-drug chemolipiodolization with sponge embolization (Arm 1)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Triple-drug chemolipiodolization without embolization (Arm 2)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Single-drug chemolipiodolization with sponge embolization (Arm 3)
Number of subjects: 365
Study: 21631360

Group type: EXPERIMENTAL
Intervention: Fertilized egg powder (Young Tissue Extract; YT®)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Fertilized egg powder (Young Tissue Extract; YT®) plus Melissa officinalis
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 19085032

Group type: EXPERIMENTAL
Intervention: Low-profile port system
Number of subjects: 80

Group type: COMPARATOR
Intervention: Regular port system (Control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80